(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-2-(thiophen-3-yl)acetic acid, 95.0%, 250mg

6-[(2-{[4-(2,4-dichlorophenyl)-5-(4-methyl-1H-imidazol-2-yl)pyrimidin-2-yl]amino}ethyl)amino]pyridine-3-carbonitrile hydrochloride, 98%, 100mg

Ethyl 2-(3-((tert-Butoxycarbonyl)amino)bicyclo[1.1.1]pentan-1-yl)acetate, 98%, 10g

2,2,2-Trifluoro-1-(2-fluorophenyl)ethan-1-amine hydrochloride, 250mg

(S)-2-(Aminomethyl)-3-methylbutanoic acid, 95.0%, 1g

Methyl 4-Amino-3-methylbenzoate>98.0%(GC)(T)5g

8-Bromo-4-chloro-quinoline-3-carbonitrile, 97.0%, 250mg

Plan Fluarex PLFi 4x/0.13 IOS infinity corrected objective. Working distance 16.3 mm

5H-Spiro[furo[3,4-b]pyridine-7,4'-piperidine] dihydrochloride, 97%, 1g

(R)-(+)-N,N-Dimethyl-1-ferrocenylethylamine>98.0%(GC)1g

4-(2,5-Diaza-bicyclo[2.2.1]hept-2-ylmethyl)-benzonitrile, 1g

(S)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-4-(2-fluorophenyl)butanoic acid, 97%, 1g

2-(Isopropylsulfonyl)ethanol, 95.0%, 5g